DYDaizo Yoshida

Daizo Yoshida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daizo Yoshida has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Signal Transduction in Pituitary Functions

    by Daizo Yoshida, Akira Teramoto

    Signal transduction plays a crucial role in the intricate functioning of the pituitary gland. Dopamine receptor type 2 (DRD2) signaling is representative. The actin-binding protein filamin A (FLNA) is essential for the expression and signaling of dopamine receptor type 2 (DRD2) in GH- and PRL-secreting pituitary tumors (PitNETs). FLNA acts, facilitating DRD2 signal transduction and influencing tumor responsiveness to dopaminergic drugs and somatostatin receptor ligands. Remarkably, when FLNA is phosphorylated at Ser2152 (P-FLNA), its role transitions from being a scaffold that facilitates SSTR2 signal transduction to becoming a signal termination protein that impairs SSTR2’s antitumoral effects in GH-secreting PitNETs. Activation of the cAMP pathway and stimulation of DRD2 agonists impact P-FLNA levels. Overexpression of a phosphomimetic (S2152D) FLNA mutant prevents DRD2’s antiproliferative effects, emphasizing the role of P-FLNA in DRD2 signaling. These include the phosphorylation of Janus Kinase (Jak) 2 and Signal Transduction and Activator of Transcription (STAT) 5. Once phosphorylated, these proteins modulate the activity of specific genes. For instance, they enhance the expression of tyrosine hydroxylase, which stimulates dopamine production, and activate the beta-casein gene, promoting milk protein synthesis. In lower vertebrates, the pituitary gland exhibits signal transduction mechanisms related to the glucagon-like peptide-1 (GLP-1) system.

  • Open Access

    Tumor Angiogenesis in Pituitary Adenoma

    by Daizo Yoshida, Akira Teramoto

    The role of angiogenesis in pituitary tumor development used to be questioned, since pituitary tumors have been usually found to be less vascularized than the normal pituitary tissue. Nevertheless, a significantly higher degree of vasculature has been shown in invasive or macropituitary prolactinomas when compared to noninvasive and microprolactinomas. We should know VEGF was found firstly in pituitary anterior lobe, then tumor angiogenesis must occur. Meanwhile the vascular arrangement raised by VEGF is irregular, that sometimes lead to pituitary apoplexy. In this chapter, hypoxia inducible factors (HIF), transcription factors regulating expression of several genes related to oxygen homeostasis are in response to hypoxic stress. We focus on tumor angiogenesis regulated by the signaling cascade in tumor angiogenesis in pituitary tumor.

  • A transfection method for short interfering RNA with the lipid-like self-assembling nanotube, A6K

    by Daizo Yoshida, K. Kim, I. Takumi, F. Yamaguchi, K. Adachi, A. Teramoto

    The aim of the present study was to develop a novel transfection method for short interfering RNA (siRNA). A nanotube with surfactant activity, A6K, consisting of six alanine residues and a hydrophilic head, lysine, was compared to the conventional cationic transfectant reagents siFECTOR and Lipofectamine 2000. Cytotoxicity for the human glioblastoma cell lines U87MG, A172, and T98G was examined with the MTS assay. Transfection efficiency was analyzed with FITC-labeled siRNA targeting matrix metalloproteinase (MMP)-2 mRNA by fluorescent activity on microscopy. The ultrastructure of A6K was evaluated by electron microscopy. The level of cytotoxicity associated with A6K in the U87MG cells was significantly lower than with siFECTOR and Lipofectamine 2000. Transfection efficiency for siRNA was increased in a dose- and time-dependent fashion. The relative expression of MMP-2 mRNA to β-actin was reduced in a dose-dependent manner by real-time RT-PCR analysis. The ultrastructure of the A6K was transformed to micelle formation when mixed with the siRNA. The lipid-like self-assembling peptide, A6K, has genes in the micelle associated with the hydrophilic tail. This transfection method is a novel and stable technique with lower cytotoxicity than the current standard methods.


  • Early computed tomography signs as early predictors of hemorrhagic transformation under heparinization in patients with cardiogenic embolism

    by Takeshi Terao, Masahiro Mishina, Ichiro Takumi, Yuichi Komaba, Takayuki Mizunari, Shiro Kobayashi, Daizo Yoshida, Akira Teramoto


  • Open Access

    Digital Imaging for Statistical Analysis of Tissue Microarrays

    by Daizo Yoshida, Akira Teramoto

    Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

  • The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells

    by D. Yoshida, K Koketshu, R. Nomura, A. Teramoto

    Pituitary adenomas produce the chemokine stromal cell-derived factor (SDF-1α/CXCL12) and its receptor, CXCR4. A recent study indicated that CXCL12 and CXCR4 are concomitantly up-regulated in hypoxia. The objective of this study was to analyze the molecular mechanism of hypoxia-mediated CXCR4 up-regulation and assess the effect of pharmacological inhibition of CXCR4 by the receptor blocker, AMD3100, on pituitary function. CXCR4 expression in pituitary adenoma tissues was determined by a tissue microarray analysis of 62 pituitary adenoma samples. CXCR4 expression was significantly elevated and positively correlated with Knosp grade in pituitary adenomas (P < 0.005), and was higher in macroadenoma and growth hormone (GH)-producing adenomas. Pre-operative serum GH levels were significantly correlated with CXCR4 levels in the microarray (P < 0.0001). The relative expression of genes/gene categories that were modulated by up-regulated CXCL12/CXCR4 signaling was determined by a comparative transcriptome analysis of wild-type and CXCR4-knockdown cells in normoxia and hypoxia using the rat GH-producing and prolactin-producing pituitary adenoma cell line, GH3. Real-time reverse transcriptase-polymerase chain reaction analysis (RT-PCR) showed that CXCR4 mRNA expression in GH3 cells was increased by hypoxia (1% oxygen), and a cDNA microarray analysis revealed that inhibin β-C expression was diminished. siRNA-mediated CXCR4 knockdown blocked the hypoxia-induced decrease in inhibin β-C mRNA expression, as did inhibition of CXCR4 activity with AMD3100. An ELISA study demonstrated that GH secretion by wild-type GH3 cells was moderately enhanced by hypoxia and further potentiated by exposure to recombinant SDF-1α/CXCL12 protein. Conversely, hypoxia-induced GH secretion was reduced in CXCR4-silenced cells and in cells treated with the CXCR4 antagonist, AMD3100, notwithstanding the presence of SDF-1α/CXCL12 protein. These latter observations reflect the failure of hypoxia to suppress expression of inhibin β-C in cells deficient in CXCR4 or in which CXCR4 signaling was blocked. Together, these results indicate that the SDF-1α/CXCL12-CXCR4 signaling pathway interfaces with the classical endocrine pathway to up-regulate GH production via suppression of inhibin β-C. Because it blocks CXCR4 and prevents hypoxia-induced down-regulation of inhibin β-C expression, AMD3100 has promise as a molecular-targeting agent in the treatment of GH-producing adenomas.


  • Signalling Pathway Mediated by CXCR7, an Alternative Chemokine Receptor for Stromal‐Cell Derived Factor‐1α, in AtT20 Mouse Adrenocorticotrophic Hormone‐Secreting Pituitary Adenoma Cells

    by D. Yoshida, R. Nomura, A. Teramoto

    Stromal cell‐derived factor (SDF)‐1 and its receptor, CXCR4, have been identified in both neurones and glia of many brain areas. Previous studies have mainly focused on the role of SDF‐1 and CXCR4 in modulating the hypothalamic‐pituitary axis and their possible involvement in the development of pituitary adenomas. An alternative SDF‐1 receptor, CXCR7, has recently been identified, but it has not been studied in the context of pituitary adenomas. The present study aimed to investigate the distribution and function of CXCR7 in pituitary adenomas. The expression of CXCR7, normalised to β‐actin, was assessed by tissue microarray analysis of 62 adenomas, including 23 growth hormone (GH)‐producing adenomas, 22 nonfunctioning adenomas, seven prolactin (PRL)‐producing adenomas, six adrenocorticotrophic hormone‐producing adenomas and four thyroid‐stimulating hormone‐producing adenomas. In vitro functional studies used RNA interference (RNAi) and cDNA microarray analysis to evaluate the CXCR7 signalling pathway in AtT‐20 mouse pituitary adenoma cells treated with recombinant mouse SDF‐1α and transfected with RNAi against Cxcr7 or control RNAi. In tissue microarray analysis, prominent expression of CXCR7 was observed in GH‐producing adenomas and PRL‐producing adenomas, and in macroadenomas (P < 0.05). Intracellular signalling via CXCR7 up‐regulated Bub1, Cdc29 and Ccnb1, and down‐regulated Asns, Gpt, Pycr1, Cars and Dars. The present study demonstrates that the SDF‐1α/CXCR7 signalling pathway regulates genes involved in cell cycle control, amino acid metabolism and ligase activity, which comprise targets that are distinct from those of CXCR4.


  • Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia

    by Ryutaro Nomura, Daizo Yoshida, Akira Teramoto

    The chemokine stromal cell-derived factor-1 (SDF-1/CXCL12) is known to have a homing effect, recruiting endothelial progenitor cells (EPCs) from the bone marrow to ischemic foci. In this study, we investigated whether SDF-1 is triggered by hypoxia and might be a major driving force for tumor angiogenesis in pituitary adenomas. SDF-1 and microvascular density (MVD) were detected by double-immunofluorescence microscopy in CD34-positive vessels from 59 cases with pituitary adenomas. In vitro secretion of SDF-1 by the AtT20 mouse pituitary adenoma cell line under hypoxic conditions was quantitatively analyzed by ELISA, and SDF-1 mRNA levels were determined by real-time RT-PCR. Double-fluorescence immunohistochemistry showed that increases in MVD were significantly correlated with increased SDF-1 grade (P < 0.0001), and, concomitantly, the expression of SDF-1 was significantly greater in macroadenomas (P = 0.0203). SDF-1 secretion was inversely related to oxygen levels, with more severe degrees of hypoxia inducing greater levels of SDF-1 secretion. Real-time RT-PCR demonstrated that the SDF-1 mRNA level in AtT20 cells was significantly increased at 1% oxygen (logarithmic mean value = 1.55 ± 0.56) compared with that at 21% oxygen. The current study strongly suggests that SDF-1 is a crucial angiogenic factor in pituitary adenomas, where it acts as a homing agent to mediate the mobilization of CD34-positive endothelial progenitor cells to the tumor parenchyma under hypoxic conditions.


  • Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK)

    by Daizo Yoshida, Ryutaro Nomura, Akira Teramoto

    Degradation and remodelling of the extracellular matrix has been investigated, with the main focus on the balance between matrix metalloproteinases (MMP) and tissue inhibitor of metalloproteinases (TIMP). Recent reports disclose the presence of a novel MMP-inhibiting cell membrane-anchored glycoprotein designated ‘reversion-inducing cysteine-rich protein with Kazal motifs’ (RECK). Our main aim in this study was to elucidate the role of RECK in cell invasion of pituitary adenomas and its contribution to signal transduction. The function of RECK in cell invasion was investigated by comparing data obtained from full-length RECK clone transfection and gene silencing with RECK mRNA-targeting siRNA. RECK expression was confirmed using real-time RT-PCR and Western blotting. Levels of matrix metalloproteinases (MMP-2 and -9) and TIMP-1 were measured by zymography and reverse zymography, respectively. Cell invasion was examined with a 3-D invasion assay. The signal cascade was investigated by cDNA microarray analysis. As expected, expression of RECK was elevated upon cDNA transfection, and diminished using siRNA. We observed elevation of MMP-2 and -9 expression and consequent 3-D cell invasion in cells under-expressing RECK. However, TIMP expression was not affected by RECK. Analysis with cDNA microarray revealed that RECK additionally upregulates growth hormone-releasing hormone receptor (GHRHR) and latrophilin 2 at the transcriptional level. Our findings collectively suggest that RECK regulates the cell signalling pathway, playing a critical neuroendocrinological role in the pituitary adenoma cell line.


  • Open Access

    The Use of 3-D Culture in Peptide Hydrogel for Analysis of Discoidin Domain Receptor 1-Collagen Interaction

    by Daizo Yoshida, Akira Teramoto

    The aim of this study is to examine a novel drop culture model using a biologically inspired self-assembling peptide: hydrogel (RAD16-I, also called PuraMatrix), which produces a nanoscale environment similar to native extracellular matrix (ECM) for a cell line weakly adherent to a plastic surface during cell culture. Our work investigates quantitatively analyzing discoidin domain receptor (DDR) 1-mediated protein interactions between collagen type I and matrix metalloproteinase (MMP)-2 or -9, as well as cell invasion, using, as a scaffold, PuraMatrix, a novel peptide hydrogel. Results demonstrate that the dynamic cell culture technique produced a highly stable reharvesting of cells throughout the constructs with HP-75, human pituitary adenoma cell line when compared to the traditional seeding methods. Secretion of MMP via collagen type I was observed quantitatively in the supernatant (EC50; MMP-2, 50.4 ng/ml: MMP-9, 57.6 ng/ml). In PuraMatrix gel impregnated with 50 ng/ml of collagen type I, transfection of the vector encoding full-length DDR1 or siRNA targeting DDR1 up- or down-regulated respectively secretion of MMP-2 and -9, and cell invasion. Our results show that incorporation of this peptide with each ECM component provides a more permissive environment to elucidate ECM to cell signal interaction.